FR2565105B1 - Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer - Google Patents

Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer

Info

Publication number
FR2565105B1
FR2565105B1 FR8500064A FR8500064A FR2565105B1 FR 2565105 B1 FR2565105 B1 FR 2565105B1 FR 8500064 A FR8500064 A FR 8500064A FR 8500064 A FR8500064 A FR 8500064A FR 2565105 B1 FR2565105 B1 FR 2565105B1
Authority
FR
France
Prior art keywords
ketosis
preparing
treatment
pharmaceutical composition
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8500064A
Other languages
English (en)
Other versions
FR2565105A1 (fr
Inventor
Karoly Magyar
Ferenc Simon
Denes Bezzegh
Jozsef Kelemen
Gabor Zalai
Attila Mislei
Peter Sarkozi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2565105A1 publication Critical patent/FR2565105A1/fr
Application granted granted Critical
Publication of FR2565105B1 publication Critical patent/FR2565105B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8500064A 1984-01-06 1985-01-04 Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer Expired FR2565105B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8440A HU191245B (en) 1984-01-06 1984-01-06 Process for the production of stbale pharmaceutical preparation against ketosis

Publications (2)

Publication Number Publication Date
FR2565105A1 FR2565105A1 (fr) 1985-12-06
FR2565105B1 true FR2565105B1 (fr) 1988-07-01

Family

ID=10947613

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8500064A Expired FR2565105B1 (fr) 1984-01-06 1985-01-04 Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer

Country Status (6)

Country Link
JP (1) JPS60214747A (fr)
BE (1) BE901433A (fr)
DE (1) DE3500187A1 (fr)
FR (1) FR2565105B1 (fr)
GB (1) GB2153670B (fr)
HU (1) HU191245B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3850429T2 (de) * 1987-03-26 1994-11-24 Univ London Verhinderung von ADP-Ribosylierung von G-Proteinen.
JP3230814B2 (ja) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション 炭酸マグネシウムおよびオイルタブレット形成助剤
US5601836A (en) * 1993-06-28 1997-02-11 Great Lakes Biochemical Company, Inc. Nutritional supplement for calving ruminant animals
GB9418420D0 (en) * 1994-09-13 1994-11-02 Mckeown Neil A Composition for the treatment of an energy imbalance in ruminents
US5560920A (en) * 1995-04-07 1996-10-01 The United States Of America, As Represented By The Secretary Of Agriculture Calcium formulations for prevention of parturient hypocalcemia
CZ329799A3 (cs) 1997-03-21 1999-12-15 Basf Aktiengesellschaft Roztok a jeho použití
US6126986A (en) * 1999-02-23 2000-10-03 Westway Trading Corporation Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid
CN104922064B (zh) * 2015-05-28 2019-01-29 广东温氏大华农生物科技有限公司 一种防治奶牛酮病的纳米级营养微乳液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156999C (fr) * 1902-04-02
US3196073A (en) * 1961-03-16 1965-07-20 Dow Chemical Co Method of tranquilizing with 1, 2-dihydroxy propane
FR1546819A (fr) * 1967-01-14 1968-11-22 Union Agricole Ag Fuer Landw S Procédé pour l'alimentation d'appoint de vaches laitières de haut rendement, en particulier avant et après le vêlage, et aliment d'appoint pour la mise en oeuvre du procédé
US3621163A (en) * 1970-01-19 1971-11-16 Acb Corp Inertia switch
DE2014844C2 (de) * 1970-03-26 1984-09-06 Boliden Ab, Stockholm Verfahren zur Herstellung eines granulierten Magnesiumoxid-Produktes
DE2518189A1 (de) * 1975-04-24 1976-11-04 Astra Ewos Ab Spurenelementkonzentrat, verfahren zu dessen herstellung und dessen verwendung
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS5344636A (en) * 1976-10-05 1978-04-21 Mitsubishi Chem Ind Ltd Remedy and prevention for milk fever
GB1596505A (en) * 1976-11-23 1981-08-26 Unilever Ltd Food manufacture
DE3010250A1 (de) * 1980-03-17 1981-09-24 Wolf Freiherr von 8183 Rottach-Egern Tucher Verwendung eines vorkonzentrats als zusatz zu mastfutter fuer saeugetiere
AT372854B (de) * 1981-02-03 1983-11-25 Moser Siegfried Dr Verfahren zur vorbeugung der entstehung gravierender gesundheitlicher stoerungen bei wiederkaeuern sowie zur wildverbissverhinderung
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
HU190866B (en) * 1984-01-06 1986-11-28 Egis Gyogyszergyar,Hu Process for producing concentratum increasing the weight output and containing agent of 1-25 mass pct. and/or animal food containing agent of 0,001-0,075 mass pct.
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same

Also Published As

Publication number Publication date
HU191245B (en) 1987-01-28
GB2153670A (en) 1985-08-29
DE3500187A1 (de) 1985-07-18
GB2153670B (en) 1988-03-23
JPH0324450B2 (fr) 1991-04-03
JPS60214747A (ja) 1985-10-28
FR2565105A1 (fr) 1985-12-06
HUT37336A (en) 1985-12-28
BE901433A (fr) 1985-07-03
GB8500143D0 (en) 1985-02-13

Similar Documents

Publication Publication Date Title
FR2568472B1 (fr) Preparations pharmaceutiques retard et procede pour les fabriquer
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2583038B1 (fr) Procede de deprotection des esters et ethers allyliques
FR2618445B1 (fr) Peinture en emulsion et procede pour sa preparation
PT73210A (fr) Procede pour la preparation de benzamides substituees et compositions pharmaceutiques qui les contiennent
FR2565105B1 (fr) Composition pharmaceutique stable pour le traitement de la cetose et procede pour la preparer
FR2496106B1 (fr) Derives d'acide 7-acylaminocephalosporanique et procede pour leur preparation
BE889604A (fr) Procede de preparation d'acetaldehyde et d'ethanol
FR2560599B1 (fr) Esters phosphoriques et procede pour leur preparation
PT84933B (fr) Procede de preparation de cyclodepsipeptides et compositions pharmaceutiques qui les contiennent
FR2565590B1 (fr) Procede de preparation d'aminohydroxycephamcarboxylates
MC1554A1 (fr) Ethers-oxydes de l'antibiotique x-14868a et procede pour leur preparation
MC1692A1 (fr) Procede de preparation de derives de phenyltetraenyle derives de phenyltetraenyle et leur application
FR2559771B1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
FR2505340B1 (fr) Procede de preparation d'anhydrides d'acides alcenyl-dicarboxyliques
FR2640140B1 (fr) Compositions pour le traitement de phlebectasies et leur procede de preparation
MC1740A1 (fr) Glyocides et procede pour leur preparation
FR2536280B1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
FR2561645B1 (fr) Procede de preparation d'acides hydroxyalkylaminoacetiques
RO87007A (fr) Procede et installation pour la preparation de l'isomerose
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2562798B1 (fr) Agent pharmaceutique pour le traitement du psoriasis
FR2566663B1 (fr) Vermicide a base de mebendazole et procede pour la preparation de ce vermicide
FR2511677B1 (fr) Procede de preparation d'esters des acides alcoxyvincaminiques et alcoxyapovincaminiques

Legal Events

Date Code Title Description
ST Notification of lapse